These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7240114)

  • 1. The clinical characteristics and treatment of atypical depression.
    Sovner RD
    J Clin Psychiatry; 1981 Jul; 42(7):285-9. PubMed ID: 7240114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression in children: relationship between plasma imipramine levels and response.
    Preskorn SH; Weller EB; Weller RA
    J Clin Psychiatry; 1982 Nov; 43(11):450-3. PubMed ID: 7174621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and psychosocial factors of anxiety and depression in breast cancer patients.
    Lueboonthavatchai P
    J Med Assoc Thai; 2007 Oct; 90(10):2164-74. PubMed ID: 18041438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenomenology and severity of major depression and comorbid lifetime anxiety disorders in primary medical care practice.
    Brown C; Schulberg HC; Shear MK
    Anxiety; 1996; 2(5):210-8. PubMed ID: 9160625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of imipramine in psychotic versus nonpsychotic depression.
    Birkenhager TK; van den Broek WW; Mulder PG; Moleman P; Bruijn JA
    J Clin Psychopharmacol; 2008 Apr; 28(2):166-70. PubMed ID: 18344726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopharmacologic validation of atypical depression.
    Liebowitz MR; Quitkin FM; Stewart JW; McGrath PJ; Harrison W; Rabkin JG; Tricamo E; Markowitz JS; Klein DF
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):22-5. PubMed ID: 6376483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings.
    Zajecka JM
    J Clin Psychiatry; 1996; 57 Suppl 2():10-4. PubMed ID: 8626357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic depression: response to placebo, imipramine, and phenelzine.
    Stewart JW; McGrath PJ; Quitkin FM; Rabkin JG; Harrison W; Wager S; Nunes E; Ocepek-Welikson K; Tricamo E
    J Clin Psychopharmacol; 1993 Dec; 13(6):391-6. PubMed ID: 8120152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age as a predictor of treatment response in endogenous depression.
    Brown RP; Sweeney J; Frances A; Kocsis JH; Loutsch E
    J Clin Psychopharmacol; 1983 Jun; 3(3):176-8. PubMed ID: 6875025
    [No Abstract]   [Full Text] [Related]  

  • 10. Antidepressants in concomitant chronic back pain and depression: doxepin and desipramine compared.
    Ward N; Bokan JA; Phillips M; Benedetti C; Butler S; Spengler D
    J Clin Psychiatry; 1984 Mar; 45(3 Pt 2):54-9. PubMed ID: 6321455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychotropic profile of essential antidepressants (amitriptyline, imipramine, desipramine, chlorimipramine): comparative study].
    Koszewska I; Beresewicz M; Puzyński S; Kalinowski A
    Psychiatr Pol; 1994; 28(1):27-38. PubMed ID: 8190817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevalence of depressive disorders in children and adolescents attending primary care. A survey with the Aquitaine Sentinelle Network].
    Mathet F; Martin-Guehl C; Maurice-Tison S; Bouvard MP
    Encephale; 2003; 29(5):391-400. PubMed ID: 14615688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical depression, atypical temperament and a differential antidepressant response to fluoxetine and nortriptyline.
    Joyce PR; Mulder RT; McKenzie JM; Luty SE; Cloninger CR
    Depress Anxiety; 2004; 19(3):180-6. PubMed ID: 15129420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbid depression and anxiety spectrum disorders.
    Gorman JM
    Depress Anxiety; 1996-1997; 4(4):160-8. PubMed ID: 9166648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression in adults with intellectual disability: symptoms and challenging behaviour.
    Hurley AD
    J Intellect Disabil Res; 2008 Nov; 52(11):905-16. PubMed ID: 18680532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in treatment response to sertraline versus imipramine in patients with nonmelancholic depressive disorders.
    Baca E; Garcia-Garcia M; Porras-Chavarino A
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):57-65. PubMed ID: 14687858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Frequency of bipolar affective disorders among depressive outpatients treated by psychiatrists].
    Rybakowski J; Suwalska A; Lojko D; Rymaszewska J; Kiejna A
    Psychiatr Pol; 2004; 38(2):203-16. PubMed ID: 15307287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prior antidepressant treatment does not have an impact on response to desipramine treatment in major depression.
    Young LT; Cooke RG; Levitt AJ; Joffe RT
    Biol Psychiatry; 1995 Sep; 38(6):410-2. PubMed ID: 8547462
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacotherapy in depression during conversion from depression to mania in patients with bipolar affective disorder].
    Koszewska I
    Psychiatr Pol; 1996; 30(1):113-25. PubMed ID: 8722244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of electroconvulsive therapy and desipramine on neuroendocrine responses to the clonidine challenge test.
    Coote M; Wilkins A; Werstiuk ES; Steiner M
    J Psychiatry Neurosci; 1998 May; 23(3):172-8. PubMed ID: 9595891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.